|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
EXP |
Aluminum Hydroxide results in decreased expression of ABCC2 protein |
CTD |
PMID:14976346 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of ACTA2 protein; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of ACTA2 protein] |
CTD |
PMID:35481609 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases expression |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of AKT1 protein; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of AKT1 protein] Aluminum Hydroxide results in increased expression of AKT1 protein [Tretinoin co-treated with BDNF protein co-treated with Aluminum Hydroxide] results in decreased expression of AKT1 protein; dihydrolipoic acid inhibits the reaction [[Tretinoin co-treated with BDNF protein co-treated with Aluminum Hydroxide] results in decreased expression of AKT1 protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide results in increased expression of AKT1 protein] |
CTD |
PMID:35481609 PMID:37409350 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of APP protein Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in increased expression of APP protein]; Coconut Oil inhibits the reaction [Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in increased expression of APP protein]]; Coconut Oil inhibits the reaction [Aluminum Hydroxide results in increased expression of APP protein] |
CTD |
PMID:37989595 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of MAPT protein; [BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of SNCA protein; [Tretinoin co-treated with Aluminum Hydroxide co-treated with BDNF protein] results in decreased expression of CTNNB1 protein; [Tretinoin co-treated with BDNF protein co-treated with Aluminum Hydroxide] results in decreased expression of AKT1 protein; Aluminum Hydroxide inhibits the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of MAPT protein]; Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in decreased expression of SLC6A3 protein]; Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in increased expression of APP protein]; Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of PPP1CA protein]; Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of WNT5A protein]; Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of GSK3B protein]; Coconut Oil inhibits the reaction [[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of MAPT protein]; Coconut Oil inhibits the reaction [[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of SNCA protein]; Coconut Oil inhibits the reaction [Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in decreased expression of SLC6A3 protein]]; Coconut Oil inhibits the reaction [Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in increased expression of APP protein]]; dihydrolipoic acid inhibits the reaction [[Tretinoin co-treated with Aluminum Hydroxide co-treated with BDNF protein] results in decreased expression of CTNNB1 protein]; dihydrolipoic acid inhibits the reaction [[Tretinoin co-treated with BDNF protein co-treated with Aluminum Hydroxide] results in decreased expression of AKT1 protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of PPP1CA protein]]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of WNT5A protein]]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of GSK3B protein]]; dihydrolipoic acid promotes the reaction [Aluminum Hydroxide inhibits the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of MAPT protein]] |
CTD |
PMID:37409350 PMID:37989595 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased activity of CASP1 protein]; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased expression of and results in increased secretion of CASP1 protein modified form]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] [Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased expression of and results in increased secretion of CASP1 protein modified form]; [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of and results in increased cleavage of CASP1 protein; [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of CASP1 mRNA; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of and results in increased cleavage of CASP1 protein]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of CASP1 mRNA] |
CTD |
PMID:18604214 PMID:22075093 PMID:38176579 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Cat |
catalase |
decreases activity multiple interactions increases activity |
EXP ISO |
Aluminum Hydroxide results in decreased activity of CAT protein [Thimerosal co-treated with Aluminum Hydroxide] results in increased activity of CAT protein Aluminum Hydroxide results in increased activity of CAT protein |
CTD |
PMID:14976346 PMID:36411272 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases secretion |
ISO |
Aluminum Hydroxide results in increased secretion of CCL2 protein |
CTD |
PMID:18390722 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases secretion |
ISO |
Aluminum Hydroxide results in increased secretion of CCL3 protein |
CTD |
PMID:18390722 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases secretion |
ISO |
Aluminum Hydroxide results in increased secretion of CCL4 protein |
CTD |
PMID:18390722 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases secretion |
ISO |
Aluminum Hydroxide results in increased secretion of CCL5 protein |
CTD |
PMID:18390722 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
multiple interactions |
ISO |
Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein] |
CTD |
PMID:18390722 |
|
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd14 |
CD14 molecule |
decreases expression |
ISO |
Aluminum Hydroxide results in decreased expression of CD14 protein |
CTD |
PMID:18390722 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd4 |
Cd4 molecule |
affects response to substance |
ISO |
CD4 protein affects the susceptibility to Aluminum Hydroxide |
CTD |
PMID:11160013 |
|
NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:157,668,878...157,695,191
|
|
G |
Cd40 |
CD40 molecule |
increases expression |
ISO |
Aluminum Hydroxide results in increased expression of CD40 protein |
CTD |
PMID:11160013 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions |
ISO |
Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein] |
CTD |
PMID:18390722 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
ISO |
Aluminum Hydroxide results in increased expression of CD83 protein |
CTD |
PMID:11160013 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd86 |
CD86 molecule |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of CD86 protein Aluminum Hydroxide promotes the reaction [CSF2 protein results in increased expression of CD86 protein] |
CTD |
PMID:11160013 PMID:18390722 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Crlf2 |
cytokine receptor-like factor 2 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of CRLF2 mRNA; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of CRLF2 protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of CRLF2 mRNA]; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of CRLF2 protein] |
CTD |
PMID:36029577 |
|
NCBI chr14:118,932...123,632
Ensembl chr14:103,939...108,642
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein]; Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein]; Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein]; Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein]; Aluminum Hydroxide promotes the reaction [CSF2 protein results in increased expression of CD86 protein] |
CTD |
PMID:18390722 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
[Tretinoin co-treated with Aluminum Hydroxide co-treated with BDNF protein] results in decreased expression of CTNNB1 protein; dihydrolipoic acid inhibits the reaction [[Tretinoin co-treated with Aluminum Hydroxide co-treated with BDNF protein] results in decreased expression of CTNNB1 protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide results in decreased expression of CTNNB1 protein] |
CTD |
PMID:37409350 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] |
CTD |
PMID:17404311 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Dbh |
dopamine beta-hydroxylase |
multiple interactions |
ISO |
[Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of DBH protein |
CTD |
PMID:36411272 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of EGFR mRNA; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of EGFR mRNA] |
CTD |
PMID:36855022 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of GATA3 mRNA; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of GATA3 mRNA] |
CTD |
PMID:36029577 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of and results in increased cleavage of GSDMD protein; [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of GSDMD mRNA; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of and results in increased cleavage of GSDMD mRNA]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of and results in increased cleavage of GSDMD protein] |
CTD |
PMID:38176579 |
|
NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions increases expression |
ISO |
Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of GSK3B protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of GSK3B protein]]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide results in increased expression of GSK3B protein] |
CTD |
PMID:37409350 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Aluminum Hydroxide results in increased expression of ICAM1 protein |
CTD |
PMID:11160013 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il13 |
interleukin 13 |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of IL13 mRNA [Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL13 protein; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL13 protein; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL13 protein]; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL13 protein]; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL13 protein] |
CTD |
PMID:9328138 PMID:35481609 PMID:36029577 PMID:36855022 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL18 mRNA; [OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL18 protein; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL18 mRNA]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL18 protein] |
CTD |
PMID:38176579 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with K-12 lipopolysaccharide] results in increased secretion of IL1B protein modified form; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein] [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL1B mRNA; [OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL1B protein; IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL1B mRNA]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:17404311 PMID:18604214 PMID:22075093 PMID:38176579 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
multiple interactions |
ISO |
IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases secretion |
ISO |
Aluminum Hydroxide results in increased secretion of IL1RN protein |
CTD |
PMID:18390722 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of IL2 mRNA [Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]; TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]] |
CTD |
PMID:9328138 PMID:22075093 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
increases expression multiple interactions affects response to substance |
ISO |
Aluminum Hydroxide results in increased expression of IL4 mRNA Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein]; Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD80 protein]; Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CCR7 protein]; Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] IL4 protein affects the susceptibility to Aluminum Hydroxide [Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL4 protein; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL4 protein; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL4 protein]; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL4 protein]; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL4 protein]; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL4 protein] |
CTD |
PMID:9328138 PMID:11160013 PMID:18390722 PMID:35481609 PMID:36029577 PMID:36855022 More...
|
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of IL5 mRNA [Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL5 protein; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL5 protein; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of IL5 protein]; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL5 protein]; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL5 protein]; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL5 protein] |
CTD |
PMID:9328138 PMID:35481609 PMID:36029577 PMID:36855022 |
|
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Aluminum Hydroxide results in increased expression of IL6 mRNA [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL6 mRNA; [OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL6 protein; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of IL6 mRNA]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of IL6 protein] |
CTD |
PMID:9328138 PMID:38176579 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL7R mRNA; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL7R protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL7R mRNA]; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of IL7R protein] |
CTD |
PMID:36029577 |
|
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Jak1 |
Janus kinase 1 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of JAK1 protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of JAK1 protein] |
CTD |
PMID:36029577 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of JAK2 protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:36029577 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of MAPK3 mRNA; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of MAPK3 mRNA] |
CTD |
PMID:36855022 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions increases expression |
ISO |
[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of MAPT protein; Aluminum Hydroxide inhibits the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of MAPT protein]; Coconut Oil inhibits the reaction [[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of MAPT protein]; Coconut Oil inhibits the reaction [Aluminum Hydroxide results in increased expression of MAPT protein]; dihydrolipoic acid promotes the reaction [Aluminum Hydroxide inhibits the reaction [[Tretinoin co-treated with BDNF protein] results in increased expression of MAPT protein]] |
CTD |
PMID:37409350 PMID:37989595 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of MUC5AC mRNA; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of MUC5AC mRNA] |
CTD |
PMID:35481609 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO |
Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein] Aluminum Hydroxide results in increased expression of NFE2L2 protein |
CTD |
PMID:36411272 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of NLRP3 protein; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of NLRP3 protein]; nonylphenol results in increased expression of [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of NLRP3 mRNA] |
CTD |
PMID:18604214 PMID:38176579 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
multiple interactions |
ISO |
Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of PPP1CA protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of PPP1CA protein]] |
CTD |
PMID:37409350 |
|
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of PTGS2 mRNA; cang er zi wan affects the reaction [[Aluminum Hydroxide co-treated with Ovalbumin] affects the expression of PTGS2 mRNA] |
CTD |
PMID:36855022 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of PYCARD mRNA; [OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of PYCARD protein; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of PYCARD mRNA]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] |
CTD |
PMID:18604214 PMID:38176579 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased phosphorylation of RELA protein; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased phosphorylation of RELA protein] |
CTD |
PMID:38176579 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
increases expression multiple interactions decreases expression |
ISO |
Aluminum Hydroxide results in increased expression of SLC6A3 protein [Thimerosal co-treated with Aluminum Hydroxide] results in increased expression of SLC6A3 protein; Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in decreased expression of SLC6A3 protein]; Coconut Oil inhibits the reaction [Aluminum Hydroxide promotes the reaction [[BDNF protein co-treated with Tretinoin] results in decreased expression of SLC6A3 protein]]; Coconut Oil inhibits the reaction [Aluminum Hydroxide results in decreased expression of SLC6A3 protein] |
CTD |
PMID:36411272 PMID:37989595 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Snca |
synuclein alpha |
multiple interactions increases expression |
ISO |
[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of SNCA protein; Coconut Oil inhibits the reaction [[BDNF protein co-treated with Tretinoin co-treated with Aluminum Hydroxide] results in increased expression of SNCA protein] Aluminum Hydroxide results in increased expression of SNCA protein |
CTD |
PMID:37989595 |
|
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of STAT3 protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:36029577 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
Aluminum Hydroxide promotes the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of TFRC protein] |
CTD |
PMID:18390722 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TGFB1 protein; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TGFB1 protein] |
CTD |
PMID:35481609 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]]; TLR4 protein affects the susceptibility to [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine]; TLR4 protein affects the susceptibility to [Aluminum Hydroxide co-treated with Magnesium Hydroxide] |
CTD |
PMID:22075093 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of TNF mRNA; [OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of TNF protein; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNF protein; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNF protein]; dioscin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNF protein]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased expression of TNF mRNA]; nonylphenol promotes the reaction [[OVAL protein co-treated with Aluminum Hydroxide] results in increased secretion of TNF protein] |
CTD |
PMID:35481609 PMID:38176579 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf4 |
TNF receptor superfamily member 4 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFRSF4 mRNA; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFRSF4 mRNA] |
CTD |
PMID:36029577 |
|
NCBI chr 5:171,889,134...171,891,824
Ensembl chr 5:166,606,909...166,609,599
|
|
G |
Tnfsf4 |
TNF superfamily member 4 |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFSF4 mRNA; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFSF4 mRNA] |
CTD |
PMID:36029577 |
|
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TSLP mRNA; [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TSLP protein; nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TSLP protein] |
CTD |
PMID:36029577 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Wnt5a |
Wnt family member 5A |
multiple interactions decreases expression |
ISO |
Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of WNT5A protein]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide promotes the reaction [[Tretinoin co-treated with BDNF protein] results in decreased expression of WNT5A protein]]; dihydrolipoic acid inhibits the reaction [Aluminum Hydroxide results in decreased expression of WNT5A protein] |
CTD |
PMID:37409350 |
|
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
|
|